Fairmount Funds Management LLC 13D and 13G filings for Damora Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-11 6:11 pm Purchase | 2026-02-09 | 13D | DAMORA THERAPEUTICS, INC DMRA | Fairmount Funds Management LLC | 8,713,000 19.990% | 8,316,000 (+2094.71%) | Filing |
| 2025-11-17 9:45 pm Purchase | 2025-11-10 | 13D | DAMORA THERAPEUTICS, INC DMRA | Fairmount Funds Management LLC | 397,000 19.990% | 397,000 (New Position) | Filing |